A nanotech therapy created by scientists at Michigan State University and Stanford University could eat away portions of the plaques that cause heart attacks, the universities announced.
Bryan Smith, associate professor of biomedical engineering at MSU, and collaborating researchers are working on a “Trojan Horse” nanoparticle that can be directed to eat debris, reducing and stabilizing plaque, the announcement states.
The research seeks to advance the treatment of atherosclerosis. The research results have been published in the scientific journal, Nature Nanotechnology.
When clinically tested, Smith said the findings are expected to reduce the risk of most types of heart attacks, with minimal side effects due to the unprecedented selectivity of his nanodrug.
Read more HERE

Gordana Vunjak-Novakovic Opens BMES Annual Meeting
This is the fifth in a series of articles highlighting some of the technologies, processes and keynote plenary sessions presented at the 2024 Annual...

NIH Prize Competitions: Crowdsourcing Biomedical Innovation
This is the sixth and final article in a series highlighting some of the technologies, processes and keynote plenary sessions presented at the 2024...

1 min read
NORTHEASTERN ENGINEERS INVESTIGATE USING NANOPARTICLES TO TREAT COVID-19 AND OTHER VIRUSES
Northeastern chemical engineer Thomas Webster, who specializes in developing nano-scale medicine and technology to treat diseases, is part of a...

WICHITA STATE ADDS BIOMEDICAL ENGINEERING PH.D. PROGRAM
Wichita State University is moving forward with a plan to create a biomedical engineering doctoral program, the universityannounced.The new Ph.D. in...

1 min read
BMES WELCOMES STACEY SANTIAGO TO THE TEAM!
Stacey Santiago joined the Biomedical Engineering Society this month as the Society's new Marketing and Communications Senior Manager.Stacey Santiago...